PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection

Experimental Cell Research

Volumn 241, Issue 2, 1998, Pages 426-434

  Hirsch, Tamara ^a   Decaudin, Didier ^a   Susin, Santos A ^a   Marchetti, Philippe ^a   Larochette, Nathanael ^a   Resche Rigon, Michèle ^b   Kroemer, Guido ^a  

^a CNRS   (France)

^b SANOFI   (France)

Author keywords

Mitochondrial transmembrane potential; Permeability transition; Programmed cell death

Indexed keywords

BENZODIAZEPINE RECEPTOR; DOXORUBICIN; ETOPOSIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL FREE SYSTEM; CELL PROTECTION; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GROWTH INHIBITION; LIGAND BINDING; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANIMALIA;

EID: 0032526746     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4084     Document Type: Article

References (56)

1. Zoratti M., Szabò I. The mitochondrial permeability transition. Biochem. Biophys. Acta Rev. Biomembr. 1241:1995;139-176.
2. Kinnally K. W., Lohret T. A., Campo M. L., Mannella C. A. Perspectives on the mitochondrial multiple conductance channel. J. Bioenerg. Biomembr. 28:1996;115-123.
3. Bernardi P., Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal. J. Bioenerg. Biomembr. 28:1996;129-136.
4. Ichas F., Jouavill L. S., Mazat J.-P. Mitochondria are excitable organelles capable of generating and conveying electric and calcium currents. Cell. 89:1997;1145-1153.
5. Kroemer G., Zamzami N., Susin S. A. Mitochondrial control of apoptosis. Immunol. Today. 18:1997;44-51.
6. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
7. Zamzami N., Susin S. A., Marchetti P., Hirsch T., Gómez-Monterrey I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1996;1533-1544.
8. Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1342.
9. Kantrow S. P., Piantadosi C. A. Release of cytochrome c from liver mitochondria during permeability transition. Biochem. Biophys. Res. Commun. 232:1997;669-671.
10. Ellerby H. M., Martin S. J., Ellerby L. M., Naiem S. S., Rabizadeh S., Salvese G. S., Casiano C. A., Cashman N. R., Green D. R., Bredesen D. E. Establishment of a cell-free system of neuronal apoptosis: Comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17:1997;6165-6178.
11. Liu X., Kim C. N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome C. Cell. 86:1996;147-157.
12. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
13. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T.-I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
14. Susin S. A., Zamzami N., Castedo M., Daugas E., Wang H.-G., Geley S., Fassy F., Reed J., Kroemer G. The central executioner of apoptosis: Multiple links between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186:1997;25-37.
15. vander Heiden M. G., Chandal N. S., Williamson E. K., Shcumacker P. T., Thompson C. B. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
16. de Jong D., Prins F. A., Mason D. Y., Reed J. C., van Ommen G. B., Kluin P. M. Subcellular localization of the Bcl-2 protein in malignant and normal lymphoid cells. Cancer Res. 54:1994;256-260.
17. Polyak K., Xia Y., Zweier J. L., Kinzler K. W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
18. Marchetti P., Castedo M., Susin S. A., Zamzami N., Hirsch T., Haeffner A., Hirsch F., Geuskens M., Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1996;1155-1160.
19. Marchetti P., Hirsch T., Zamzami N., Castedo M., Decaudin D., Susin S. A., Masse B., Kroemer G. Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157:1996;4830-4836.
20. Hortelano S., Dallaporta B., Zamzami N., Hirsch T., Susin S. A., Marzo I., Bosca L., Kroemer G. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett. 410:1997;373-377.
21. Hirsch T., Marchetti P., Susin S. A., Dallaporta B., Zamzami N., Marzo I., Geuskens M., Kroemer G. The apoptosis-necrosis paradox: Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene. 15:1997;1573-1582.
22. Beutner G., Rück A., Riede B., Welte W., Brdiczka D. Complexes between kinases, mitochondrial porin, and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett. 396:1996;189-195.
23. McEnery M. W., Snowman A. M., Trifiletti R. R., Snyder S. H. Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. USA. 89:1992;3170-3174.
24. Kinnally K. W., Zorov D. B., Antonenko Y. N., Snyder S. H., McEnery M. W., Tedeschi H. Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc. Natl. Acad. Sci. USA. 90:1993;1374-1378.
25. O'Gorman E., Beutner G., Dolder M., Koretsky A. P., Brdiczka D., Wallimann T. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414:1997;253-257.
26. Marzo I., Brenner C., Zamzami N., Susin S. A., Beutner G., Brdiczka D., Rémy R., Xie Z.-H., Reed J. C., Kroemer G. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2 related proteins. J. Exp. Med. 1998.
27. Zamzami N., Marzo I., Susin S. A., Brenner C., Larochette N., Marchetti P., Reed J., Kofler R., Kroemer G. The thiol-crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene. 16:1998;1055-1064.
28. Green D. R., Mahboubi A., Nishioka W., Oja S., Echeverri F., Shi Y., Glynn J., Yang Y., Ashwell J., Bissonnette R. Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals. Immunol. Rev. 142:1994;321-342.
29. Cuende E., Alés-Martínez J. E., Ding L., González-García M., Martínez-A. C., Nuñez G. Programmed cell death by Bcl-2-dependent and -independent mechanisms in B cell lymphoma cells. EMBO J. 12:1993;1555-1560.
30. Strasser-Wozak E., Hattmannstorfer R., Hala M., Hartmann B. L., Fiegl M., Geley S., Kofler R. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res. 55:1995;348-353.
31. Vayssière B. M., Dupont S., Choquart A., Petit F., Garcia T., Marchandeau C., Gronemeyer H., Resche-Rigon M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo. Mol. Endocrinol. 11:1997;1245-1255.
32. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.
33. Kroemer G., Lisardo B., Zamzami P., Hortelano S., Martinez-A. C. Detection of apoptosis and apoptosis associated alterations. The Immunology Methods Manual. 1997;Academic Press, San Diego. p. 1111-1125.
34. Petit P. X., O'Connor J. E., Grunwald D., Brown S. C. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur. J. Biochem. 220:1990;389-397.
35. Wood E. R., Earnshaw W. C. Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II. J. Cell Biol. 111:1990;2839-2850.
36. Susin S. A., Zamzami N., Larochette N., Dallaporta B., Marzo I., Brenner C., Hirsch T., Petit P. X., Geuskents M., Kroemer G. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: Application to ceramide-induced apoptosis. Exp. Cell Res. 236:1997;397-403.
37. Ripond J., Mattei M. G., Kaghad M., Dumont X., Guillemot J. C., Lefur G., Caput D., Ferrara P. Molecular cloning and chromosomal localization of a human peripheral type benzodiazepin receptor. Eur. J. Biochem. 2:1991;305-311.
38. Joseph-Liauzun E., Farges R., Delmas P., Ferrara P., Loison G. The M-r 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier. J. Biol. Chem. 272:1997;28102-28106.
39. Yeliseev A. A., Krueger K. E., Kaplan S. A mammalian mitochondrial drug receptor functions as a bacterial "oxygen" sensor. Proc. Natl. Acad. Sci. USA. 94:1997;5101-5106.
40. Farges R., Joseph-Liauzun E., Shire D., Caput D., Le Fur G., Ferrara P. Site-directed mutagenesi of the peripheral-type benzodiazepine receptor: Identification of amino acids implicated in the finding site of Ro5-4864. Mol. Pharmacol. 46:1994;1160-1167.
41. Chiou L. C., Ling J. Y., Chang C. C. Enhancement by benzodiaepines of the inhibitory effect of adenosine on skeletal neuromuscular transmission. Br. J. Pharmacol. 116:1995;1870-1874.
42. Zisterer D. M., Williams D. C. Peripheral-type benzodiazepin receptors. Gen. Pharmacol. 29:1997;305-314.
43. Decaudin D., Geley S., Hirsch T., Castedo M., Marchetti P., Macho A., Kofler R., Kroemer G. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57:1997;62-67.
44. Pastorino J. G., Simbula G., Yamamoto K., Glascott P. A. J., Rothman R. J., Farber J. L. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 271:1996;29792-29799.
45. Schulze-Osthoff K., Krammer P. H., Dröge W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13:1994;4587-4596.
46. Leist M., Single B., Castoldi A. F., Kühnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1997;1481-1486.
47. Nicotera P., Leist M. Energy supply and the shape of death in neurons and lymphoid cells. Cell Death Differ. 4:1997;435-442.
48. Boise L. H., Thompson C. B. Bcl-XL can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:1997;3759-3764.
49. Reed J. C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
50. Yasuhara N., Sahara S., Kamada S., Eguchi Y., Tsujimoto Y. Evidence against a functional site for Bcl-2 downstream of caspase cascade in preventing apoptosis. Oncogene. 15:1997;1921-1928.
51. Strasser A., Harris A. W., Huang D. C. S., Krammer P. H., Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:1995;6136-6147.
52. Huang D. C. S., Cory S., Strasser A. Bcl-2, Bcl-XL, and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene. 14:1997;405-414.
53. Haldar S., Jena N., Croce C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA. 92:1995;4507-4511.
54. Haldar S., Chintapalli J., Croce C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56:1996;1253-1255.
55. Evtodienki Y. V., Teplova V. V., Sidashi S. S., Ichas F., Mazat J.-P. Microtubule-active drugs suppress the closure of the permeability transition pore in tumour mitochondria. FEBS Lett. 393:1996;86-88.
56. Carayon P., Portier M., Dussossoy D., Bord A., Petitpretre G., Canat X., Le Fur G., Casellas P. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical species. Blood. 87:1996;3170-3178.